BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23508108)

  • 1. RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity.
    Druker J; Liberman AC; Antunica-Noguerol M; Gerez J; Paez-Pereda M; Rein T; Iñiguez-Lluhí JA; Holsboer F; Arzt E
    Mol Cell Biol; 2013 Jun; 33(11):2116-27. PubMed ID: 23508108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.
    Holmstrom SR; Chupreta S; So AY; Iñiguez-Lluhí JA
    Mol Endocrinol; 2008 Sep; 22(9):2061-75. PubMed ID: 18562626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.
    Carbia-Nagashima A; Gerez J; Perez-Castro C; Paez-Pereda M; Silberstein S; Stalla GK; Holsboer F; Arzt E
    Cell; 2007 Oct; 131(2):309-23. PubMed ID: 17956732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51.
    Antunica-Noguerol M; Budziñski ML; Druker J; Gassen NC; Sokn MC; Senin S; Aprile-Garcia F; Holsboer F; Rein T; Liberman AC; Arzt E
    Cell Death Differ; 2016 Oct; 23(10):1579-91. PubMed ID: 27177020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of RSUME in inflammation and cancer.
    Antico Arciuch VG; Tedesco L; Fuertes M; Arzt E
    FEBS Lett; 2015 Nov; 589(22):3330-5. PubMed ID: 26297826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function.
    Davies L; Karthikeyan N; Lynch JT; Sial EA; Gkourtsa A; Demonacos C; Krstic-Demonacos M
    Mol Endocrinol; 2008 Jun; 22(6):1331-44. PubMed ID: 18337589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
    Tedesco L; Elguero B; Pacin DG; Senin S; Pollak C; Garcia Marchiñena PA; Jurado AM; Isola M; Labanca MJ; Palazzo M; Yankilevich P; Fuertes M; Arzt E
    Cell Death Dis; 2019 Mar; 10(4):266. PubMed ID: 30890701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of glucocorticoid receptor transcriptional activity by sumoylation.
    Le Drean Y; Mincheneau N; Le Goff P; Michel D
    Endocrinology; 2002 Sep; 143(9):3482-9. PubMed ID: 12193561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macromolecular translocation inhibitor II (Zn(2+)-binding protein, parathymosin) interacts with the glucocorticoid receptor and enhances transcription in vivo.
    Okamoto K; Isohashi F
    J Biol Chem; 2005 Nov; 280(44):36986-93. PubMed ID: 16150697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages.
    Rollins DA; Kharlyngdoh JB; Coppo M; Tharmalingam B; Mimouna S; Guo Z; Sacta MA; Pufall MA; Fisher RP; Hu X; Chinenov Y; Rogatsky I
    Nat Commun; 2017 Nov; 8(1):1739. PubMed ID: 29170386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes.
    Fuertes M; Elguero B; Gonilski-Pacin D; Herbstein F; Rosmino J; Ciancio Del Giudice N; Fiz M; Falcucci L; Arzt E
    Front Endocrinol (Lausanne); 2022; 13():864780. PubMed ID: 35528020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicity.
    Fuertes M; Sapochnik M; Tedesco L; Senin S; Attorresi A; Ajler P; Carrizo G; Cervio A; Sevlever G; Bonfiglio JJ; Stalla GK; Arzt E
    Endocr Relat Cancer; 2018 Jun; 25(6):665-676. PubMed ID: 29622689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity.
    Budziñski ML; Sokn C; Gobbini R; Ugo B; Antunica-Noguerol M; Senin S; Bajaj T; Gassen NC; Rein T; Schmidt MV; Binder EB; Arzt E; Liberman AC
    Mol Psychiatry; 2022 May; 27(5):2533-2545. PubMed ID: 35256747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response.
    Verhoog NJ; Du Toit A; Avenant C; Hapgood JP
    J Biol Chem; 2011 Jun; 286(22):19297-310. PubMed ID: 21474440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.
    Wu Y; Tedesco L; Lucia K; Schlitter AM; Garcia JM; Esposito I; Auernhammer CJ; Theodoropoulou M; Arzt E; Renner U; Stalla GK
    Oncotarget; 2016 Sep; 7(36):57878-57893. PubMed ID: 27506944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress.
    Kino T; Ichijo T; Amin ND; Kesavapany S; Wang Y; Kim N; Rao S; Player A; Zheng YL; Garabedian MJ; Kawasaki E; Pant HC; Chrousos GP
    Mol Endocrinol; 2007 Jul; 21(7):1552-68. PubMed ID: 17440046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1.
    Dobrovolna J; Chinenov Y; Kennedy MA; Liu B; Rogatsky I
    Mol Cell Biol; 2012 Feb; 32(4):730-9. PubMed ID: 22158970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression.
    Chinenov Y; Sacta MA; Cruz AR; Rogatsky I
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20185-90. PubMed ID: 19074285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor alpha receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators.
    Kino T; Chrousos GP
    J Biol Chem; 2003 Jan; 278(5):3023-9. PubMed ID: 12477726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.